RPS3AP34: A Promising Drug Target / Biomarker (G100271260)

Target Name: RPS3AP34

NCBI ID: G100271260

RPS3AP34

Other Name(s): RPS3A pseudogene 34 | RPS3A_15_876

RPS3AP34: A Promising Drug Target / Biomarker

The protein RPS3AP34 is a member of the Rho family of GTPases, which are a group of small GTPases that play a crucial role in various cellular processes. RPS3AP34 is a 34 kDa protein that is expressed in various tissues and cells, including muscle, heart, and neurons. It is known to participate in the regulation of cell proliferation, differentiation, and survival, and is involved in a wide range of physiological processes that are critical for the maintenance of tissue homeostasis.

Drug Targeting

RPS3AP34 is a potential drug target due to its unique structure and function. The RPS3AP34 protein is a GTPase that is involved in the regulation of protein kinase (PK) signaling, which is a critical pathway that regulates cell proliferation and survival. PK signaling is a complex process that involves the recruitment of various protein kinases, including RPS3AP34, to the active site of a target protein.

The N-terminus of RPS3AP34 contains a unique domain that is involved in the regulation of PK signaling. This domain is known as the N-terminal GTP-binding domain (N-GDD), and it is a critical region that plays a crucial role in the regulation of PK signaling. The N-GDD is responsible for the recruitment of PKC, a protein that is known to interact with RPS3AP34 and enhance its GTPase activity.

The C-terminus of RPS3AP34 contains a region that is involved in the regulation of cell survival. This region is known as the C-terminal hypervariable region (HVR), and it is a region that is highly conserved among different species. The C-HVR is involved in the regulation of cell survival by affecting the levels of the protein p53, which is a well-known tumor suppressor protein.

Biomarker

RPS3AP34 is also a potential biomarker for various diseases, including cancer. The regulation of PK signaling is a critical pathway that is altered in many types of cancer, including breast, ovarian, and prostate cancers. Therefore, RPS3AP34 may be a useful biomarker for the diagnosis and treatment of these diseases.

In addition to its potential as a drug target, RPS3AP34 is also a potential biomarker for neurodegenerative diseases. The regulation of PK signaling is involved in the development and progression of many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, RPS3AP34 may be a useful biomarker for the diagnosis and treatment of these diseases.

Conclusion

RPS3AP34 is a protein that is involved in the regulation of PK signaling and cell survival. Its unique structure and function make it a potential drug target and biomarker for various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the role of RPS3AP34 in these processes and to develop effective treatments.

Protein Name: RPS3A Pseudogene 34

The "RPS3AP34 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS3AP34 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets